Patient voice deserves the rigor required for decision-making.
Voice2Evidence helps pharma teams translate patient voice into evidence-ready strategy across Medical Affairs, HEOR, Market Access, Regulatory Affairs, Commercial, Patient Engagement, and Leadership.
It is AI-enabled, expert-validated, evidence-informed, and lifecycle-aware — designed to move patient experience from insight to implication to action.
Voice2Evidence is built and operated by MarksMan Healthcare — a scientific communications and evidence consultancy with expertise across HEOR, Medical Affairs, real-world evidence, market access, and patient evidence strategy.
A services engagement. Not a software subscription.
Clients do not buy seats, licenses, or platform access.
Each engagement is scoped around an asset, indication, lifecycle stage, geography, and evidence need. The workspace supports delivery, collaboration, and review — it is not a separately priced software product.
Scoped to Your Asset
Every engagement is shaped around your molecule, indication, patient segment, geography, and lifecycle stage.
AI-Enabled. Expert-Validated.
AI helps capture and structure patient voice. Senior HEOR and patient evidence experts validate interpretation and recommendations.
Output-Defined
Expected outputs are agreed upfront and aligned to the engagement objective.
Cross-Functional by Design
Patient themes are translated into recommendations for the teams responsible for action.
Confidential. Non-obligatory.
Scoping conversations are confidential and non-obligatory.
Engagements are sized to the asset, lifecycle stage, geography, evidence need, and cross-functional teams involved.
Tell us where you are in the lifecycle. We’ll show you what voice can become.
45-min strategic walkthrough · Confidential